The inhibitory effect of a series of 5'-0-am ino acid and oligopeptide derivatives of uridine on rat liver UDP-glucuronosyltransferase (U G T) activities was investigated using two assay systems. A quantitative structure-activity relationship (Q SA R ) study was performed. The compounds include a lipophilic residue linked to the nucleoside by a variable spacer. More over, half of the derivatives have two spacers linked to the uridine moiety. Compound 1, a serine derivative of isopropylideneuridine, was found to be the most potent inhibitor of both 4-nitrophenol (4-NP) and phenolphthalein (PPh) glucuronidation, with an I50 of 0.45 m M and 0.22 m M , respectively. Kinetic studies with this substance revealed a mixed type of inhibition towards 4-NP and UDP-glucuronic acid, with apparent Ki values of 150 ^m and 120 (.i m , respectively. The dipeptide derivatives 11-14 exhibited a low activity against 4-NP conjuga tion. However, a marked suppression of PPh glucuronidation was found with compounds 11 and 13. Generally, compounds with two spacers are more inhibitory against the U G T activi ties studied. The Q SA R analysis outlined the significance of the spacers with a minimum length of 5 atoms and lipophilic residues linked to them for the inhibitory effect of the compounds. The most significant contribution to this effect is given by the six-atom spacer for both, 4-NP and PPh substrates. 4-NP converting U G T isoforms seem to respond more specifically to the inhibitors: a five-atom for the first and a six-atom for the second spacer enhance binding to both 4-NP and PPh conjugating isoenzymes, while a long second spacer contributes to inhibitor binding to U G T isoforms only converting PPh.
Introduction

UDP-glucuronosyltransferase
(UGT, EC 2.4.1.17) is a family of membrane-bound isoen zymes that play an important role in the biotrans formation and detoxification of a large variety of xenobiotics and endogenous compounds (Bock et al., 1986; Tephly and Burchell, 1990; Clarke and Burchell, 1994; Bock and Lilienblum, 1994) . The enzymes catalyze the transfer of glucuronic acid from UDP-glucuronic acid (U D PG A ) to the re spective aglycones containing hydroxyl-, amino-, carboxyl-or sulfhydryl-groups, forming water-soluble ß-(ö)-glucuronides. Various drugs are exten sively converted to inactive glucuronides in this way and subsequently excreted from the organism Reprint requests to K. Grancharov. Fax: +359 2 723 507. E mail: KGran@obzor.bio21.acad.bg (Miners and Mackenzie, 1991) . Thus, the inhibi tion of U G T could increase the plasma level and therapeutic efficacy of a number of drugs. Simulta neously, the development of selective inhibitors of U G T could also be an useful approach in studying the active sites of different U G T isoforms.
Several classes of U G T inhibitors have been re cently developed, including alkanoic and arylalkanoic acids and related derivatives (Fournel et al., 1986; Fournel-Gigleux et al., 1989; Noort et al., 1990; Said et al., 1992) . We found some potent and specific inhibitors of U G T among a wide range of pyrimidine derivatives, considered as analogs of uracil or uridine moiety of U D PG A (Naydenova et al., 1995) . According to the current presen tations, the UD P part or the uridine moiety is thought to provide most of the free binding energy of the ligand-enzyme complex (Hochman and Zakim, 1983) . Thus, the synthesis of new inhibitors is directed to structures with full analogy to either UDP part (Noort et al., 1990) or uridine moiety 0939-5075/ 98/ 0300-0173 $ 06.00 © 1998 Verlag der Z eitschrift für Naturforschung. A ll rights reserved. D (Paul et al., 1993) . Linkage of lipophilic aryl-or arylalkyl-residues to U D P led to powerful selec tive U G T inhibitors, considered as possible transi tion-state analogs (Noort et al., 1990; Said et al., 1992) . These compounds were designed to take advantage of both, the high affinity of U G T for UDP part of U D PG A and the specific structural requirements for an acceptor substrate (aglycone). It was suggested that the both phosphate groups might be required for correct binding (Noort et al., 1990) . However, structurally related compounds, in which the linker between uridine and aglycone was replaced by a diphosphate-like five-atom spacer ( -0 C 0 N H S 0 2 0 -) , have been reported to be strong inhibitors of diverse U G T isoforms and some of them to behave as possible transitionstate analogs (Paul et al., 1993; Radominska et al., 1994; Battaglia et al., 1995) . This offers the possi bility, by varying this spacer, to design novel active-site directed inhibitors, based on the pre sumed transition-state for the glucuronidation reaction.
In an attempt to develop such U G T inhibitors, various protected amino acids and some dipep tides were linked to 5 '-0-position of isopropylideneuridine, thus introducing different spacers be tween the nucleoside and the lipophilic residue. Moreover, two spacers linked to the uridine moi ety could be suggested for the half of the deriva tives. As these spacers contain a number of single bonds allowing rotation, one can presume that they could behave in a similar way in relation to the active-site binding of the nucleoside and agly cone residues. In this work the inhibitory effect of these compounds on U G T in rat liver microsomes is presented, using 4-nitrophenol (4-NP) and phenolphthalein (PPh) as substrates. Glucuronidation of these aglycones is associated with different U G T isoforms, present in the rat liver (Wishart, 1978) . To estimate the contribution of the different spacers and acceptor substrates to the active-site binding, a quantitative structure-activity relation ship (Q SA R ) study was performed to outline the structural features of importance for the inhibitory potency of these compounds and possibly further to direct the rational design of new U G T in hibitors.
Materials and Methods
Materials
Derivatives 1 -8 were synthesized as described in detail (Alargov et al., 1997) . The synthesis of
is comprehensively described in a concomitant pa per. Briefly, compound 11 was synthesized by the DCC/HOBt method from N-terf.butyloxycarbonyl-O-benzyl-L-serine and 5'-0-L-valyl-2',3'-0-isopropylideneuridine in 95% yield after gel chroma tography. In a similar way, compound 13 was obtained from N-terr.butyl-oxycarbonyl-L-valine and 5'-0-(0-benzyl-L-seryl)-2',3'-0-isopropylideneuridine in 93% yield. Treatment of 11 and 13 with HCl/EtOAc at room temperature for 30 min led to removal of both, Boc-and 2\3'-0-isopropylidene groups giving compounds 12 and 14 in 94% and 91% yields, respectively. The new deriva tives were TLC pure and were characterized by MS, *H NMR and elemental analysis. All other chemicals were purchased from Sigma.
Preparation o f microsomes
Liver microsomes from male Wistar rats were prepared by differential centrifugation (lOOOOxg for 10 min and 105 000x g for 60 min). The microsomal pellets were suspended in 0.1 m Tris [Tris(hydroxymethyl)aminomethane]/HCl buffer (pH 7.4) containing 0.25 m sucrose and stored at -7 0 °C until used (Matsui and Watanabe, 1982) . The microsomal protein was determined by the method of Lowry et al. (1951) with bovine serum albumin as a standard.
Enzyme assay
U G T activities towards 4-nitrophenol (4-NP) or phenolphthalein (PPh) were assayed as described previously (Naydenova et al., 1995) . Glucuronida-tion was measured on microsomes activated by the nonionic detergent Lubrol-17A. The optimal mass ratio of detergent to protein was 0.25. The mixture of microsomes and detergent was preincubated at 4 °C for 30 min. The transferase activity was mea sured colorimetrically at 405 nm for 4-NP or at 550 nm for PPh. The specific activity was ex pressed as nmoles of glucuronide formed per min per mg protein. All derivatives tested were color less and were added at a final concentration of 1 m M , dissolved in DMSO. The final concentration of DM SO in the incubation mixture was 2% . The control specific activity of U G T towards 4-NP in the presence of DM SO was 17.23±2.16 nmol/ minxmg. For glucuronidation of PPh this value was 2.87 ± 0.4 nmol/minxmg.
The apparent Ki values were determined from graphical Dixon's plots of 1/V versus [I] varying the inhibitor concentrations between 0 . 2 and 0.8 m M .
QSAR analysis
The Fujita-Ban variant of the Free-Wilson analysis was used as a basic method in the Q SA R study (Seydel and Schaper, 1979) . It is a multivari ate technique for analyzing Q SA Rs by dividing the chemical structures into structural parts and features: substructures, substituents, residues, etc. The biological activity, A, is expressed as a sum of activity contributions: A = 2 j2 k CjkX jk + A 0, where X jk has a value of one if the feature k is present in part j and zero otherwise, Cjk is the corresponding regression coefficient, and A 0 is activity of a refer ence structure. Multiple linear regression (M LR) was applied for a structural feature selection. The statistical evaluation of the Q SA Rs was done on the basis of the coefficient of multiple determina tion R 2, regression coefficient B and variable signi ficance p.
Results
Structure o f the inhibitors
The compounds investigated in the present study contain a hydrophilic uridine moiety con nected to lipophilic residues by varying spacers (amino acid residues). The most common is the five-atom oo-oxypropionate (-OCH 2 CH(NH)-COO-) spacer (see Fig. 1 ), which links benzyl (1, o o 
S -C H -O-CH -CH-(Ü -O-C H
2, 9, 10, 13, 14) or tert.butyl (7, 8) moieties to uri dine (Urd) or isopropylideneuridine (iUrd). In compounds 3, 4, 5 and 6 this spacer is shortened by omitting the co-oxygen. Besides this first spacer, the compounds 1, 3, 5, 7 and 9 could be suggested to contain also a second six-atom bridge (-OCONHCHCOO-) linking rm.butyl (1, 3, 5) or benzyl (7, 9) moieties to the nucleoside. In dipep tide derivatives 11 and 12 the co-oxypropionate spacer is linked to Urd (iUrd) via a valyl residue, forming an eight-atom serylvalyl first spacer (-OCH2 CH(NH)CONHCHCOO-). In compounds 11 and 13, a second nine-atom spacer (-OCONHCHCONHCHCOO-) could be sug gested (Fig. 2) .
Inhibitory effect on the U G T activities
In order to determine the inhibitory potency of these compounds they were tested on the glucuronidation of 4-NP and PPh by microsomal UGTs. The results expressed as a percent inhibition of the control enzyme activities are presented in Table I . Table I 
4-NP-UGT, 4-nitrophenol UDP-glucuronosyltransferase activity. PPh-UGT. phenolphthalein UDP-glucuronosyltransferase activity. Boc, tert. butyloxycarbonyl; Bzl, benzyl; iUrd, isopropylideneuridine; Urd, uridine; Bul, tert. butyl; Z, benzyloxycarbonyl.
Compound 1, the serine derivative of iUrd (Fig. 1) , was found to be the most potent inhibitor of both, 4-NP and PPh glucuronidation, with I5 0 values of 0.45 m M and 0.22 m M , respectively. Leucine and valine derivatives 3 and 5 were also active, exert ing at 1 m M concentration a similar decrease in 4-NP or PPh conjugation (4 9 -5 5 % ). These data have been published in a preliminary note (Naydenova et al., 1996) . The compounds containing the respective un protected L-amino acids, 2, 4 and 6 , were low active towards the U G T activities studied. Among the threonine derivatives, compound 7 showed a selective inhibition potency against 4-NP glucuro nidation (47% ). Derivatives 8, 9 and 10 were less inhibitory towards 4-NP conjugation, and only compound 10 showed some activity against PPh convertion. Dipeptide derivatives 1 1 -1 4 exerted as a whole a low inhibitory effect on the 4-NP-U G T activity. However, a significant decrease in PPh glucuronidation was registered with com pounds 11 and 13 (70% and 65% , respectively).
Kinetic studies were carried out with the most potent inhibitor, compound 1. Its interactions with the microsomal U G T isoforms, converting 4-NP, were characterized by varying both the concentra tion of 4-NP (0.1 to 0.8 m M ) and U D PG A (0.25 to 8 m M ), using inhibitor concentrations between 0.2 and 0.8 m M . A mixed type of inhibition towards 4-NP and U DPGA was found (Fig. 3 a, b) , and apparent Ki values of 150 (xm and 120 (im, respec tively, were determined by Dixon's plots of the data (1/V versus [I]). These results suggest that compound 1 competes, at least in part, with both substrates for their binding sites in the molecules of 4-NP converting U G T isoenzymes.
QSAR study
In the Q SA R analysis the same mechanism of action for all compounds is assumed. This demand is a prerequisite for each Q SA R study although its fulfilment is not known, especially in the case of complex enzyme-inhibitor interactions, where closely related analogs may bind in very different manners. Several ways of structural data organiza tion (data structuring) were experimented. The uri dine moiety was considered as a conservative part of the structure independently of its form (iUrd or Urd) as no definitive information about its influ ence on the inhibitory effect was available in ad vance. As well, the results of other authors do not allow any particular conclusion to be drawn on the higher inhibitory potency of the isopropylideneu ridine versus uridine form (Battaglia et al., 1995) . In the study a percent inhibition effect was used al though not recommendable for Q SA Rs due to the nonlinear characteristics of dose-response curves. Nevertheless, the presented Q SA R analysis aims some quantitative estimation to be done as to which structural features might be responsible for the bio logical activity of interest presuming equal possi bilities for active-site binding of nucleoside and aglycone residues by more than one spacer.
The structures were considered as consisting of two main variable parts: related to first ( 1 st) and second (2nd) spacers (Table II, see Fig. 1 ).
In the first structuring the length of the spacers (here and further every spacer is considered to start from the 5 '-0 -atom of the uridine moiety) was experimented as indicator variables: short (less than 5 atoms), five-atom and long (more than 5 atoms) for the 1st spacer; no (no 2nd spacer pre sented), six-atom and long (more than 6 atoms) for the 2nd spacer. The structure with a short 1st spacer and no 2 nd spacer was chosen to be a refer ence. No significant structural features were iden tified for PPh and the six-atom 2nd spacer only was estimated as contributing significantly to the inhibitory effect for 4-NP with a moderate fitting quality (R 2=0.614, p<0.05). Taking into account the possible rotational hindrance around the single bonds of the 3rd carbon atom (where the two spacers split) by the methyl-group substituent on the next carbon atom (compounds 7 and 9), an additional structural feature was experimented for these inhibitors. Once again the six-atom 2nd spacer was estimated as significant for 4-NP (R 2= 0.813, p<0.008). For PPh the five-atom and a long 1 st spacer and the six-atom and a long 2 nd spacer were estimated as significant (R 2 =0.955, p<0.00004). For both substrates the presence of methyl-group next to the 3rd spacer atom was also significant with a negative contribution to the in hibitory effect. These results directed the final structuring to be detailed on the five-atom 1 st spacer and the six-atom 2 nd. [UDPGA] mM ' 1 Table II . Indicator variables used in the Q SA R study of the U G T inhibitors. five-Bu':
Bu\ tert. butyl; Bzl, benzyl.
The indicator variables used for structural fea tures designation in the final Q SA R study are pre sented in Table II : 1st spacer {short, consisting of less than 5 atoms; five-Bu', five-atom spacer with tert. butyl residue; five-Bzl, five-atom spacer with benzyl residue; long 1st, eight-atom or dipeptide spacer with benzyl residue); 2 nd spacer (no, no spacer presented; six-Bu', six-atom spacer with tert. butyl residue; six-Bzl, six-atom spacer with benzyl residue; long 2nd, nine-atom or dipeptide spacer with tert.butyl residue). As compounds 3 and 5, and 4 and 6 are presented by the same structural features and possess very close inhibi tory effects, the final M LR run was performed without compounds 5 and 6 . Again, the structure with a short 1 st and no 2 nd spacer was chosen as a reference (compound 4). Table III a, b and Fig. 4 a, b for 4-NP and PPh substrates, respectively. In case of 4-NP, the six-atom 2nd spacer with tert. butyl residue is significant (Table Ilia ) . In case of PPh, the five-atom and a long 1 st spacer with benzyl residue and the sixatom and a long 2 nd spacer with butyl and benzyl residues are significant (Table III b) . Suggesting a positive influence of the lipophilicity of the aglycone analog residue for the enzyme inhibition (Noort et al., 1990) one could expect that more lipophilic the residue more potent the inhibitor. However, taking into account that the lipophilicities of the benzyl and tert. butyl substituents are very close (Rekker and Mannhold, 1992) , neither of them was considered as an individual indicator variable. Both the substituents were estimated to be significant when linked to the relevant spacers. The fitting quality of the models could be consid ered as very good according to R 2 values (0.785 and 0.972 for 4-NP and PPh, respectively, Table  III ) and the plots of predicted versus observed in hibitory effects (Fig. 4) .
The final M LR results are presented in
Discussion
In the past years, several active-site directed U G T inhibitors have been designed, and some of them shown to behave as analogs of the presumed transition-state of the glucuronidation reaction, catalyzed by UGT. They combined structural fea tures of the both substrates: the hydrophilic uri dine moiety and the lipophilic acceptor residue, connected by diphosphate or diphosphate-like five-atom spacers.
In this study, novel uridinyl analogs, modified at 5'-0-position by protected and unprotected amino acids, were tested as inhibitors of diverse rat liver UGTs and their structure-activity relationships an alyzed by a relevant Q SA R approach.
In general, the Q SA R analysis outlined the sig nificance of the spacers with length of minimum five atoms and lipophilic residues linked to them for the U G T inhibitory effect of the compounds studied. This finding is in agreement with the ex isting understanding for a five-atom spacer as in the U DP part (Noort et al., 1990; Battaglia et al., 1995) . However, according to the variable signifi cance, the most significant contribution to the in hibitory effect is given to the six-atom spacer (starting and ending by oxygen atoms and contain ing rotatable bonds) for both, 4-NP and PPh substrates. One can presume that both the spacers could play a role with a stronger influence of the sixatom 2nd spacer. Generally, the compounds sug gested to carry two spacers linked to Urd (iUrd) are more inhibitory against enzyme activities studied than those with one spacer only. In our preliminary publication we have assumed that both, the lipophilic benzyl moiety and the fiveatom oo-oxypropionate spacer (compound 1 ) con tribute to the high inhibitory potential (Nayde nova et al., 1996). However, in compound 1 a se cond six-atom spacer could be considered, linking iUrd and a lipophilic tert. butyl moiety. The abol ishment of this spacer by removing of the N-protecting terf.butyloxycarbonyl residue abolished the inhibitory activity (compound 2). The same holds true for derivatives 4 and 6 , which are unprotected forms of 3 and 5 (Table I) . Obviously, the six-atom spacer linking tert. butyl to uridine residue contrib utes significantly to the inhibitory potency of the compounds.
The dipeptide derivatives containing a long (eight-atom) first (11, 12) and/or a long (nineatom) second (11, 13) spacers are much less active against 4-NP glucuronidation as compared with compound 1. However, the nine-atom second spacer in compounds 11 and 13 is favourable for their binding to the molecules of PPh conjugating U G T isoenzymes. Additionally, the tert.butyl resi due in these compounds also seems to facilitate this binding.
To check the role of the first spacer on the inhib itory effect, a new compound, 5'-0-(N-te/t.butyloxycarbonyl-L-seryl)-2',3'-0-isopropylideneuridine, similar to the most potent inhibitor was synthe sized with no aglycone residue linked to the first spacer (see Fig. 1 ). The lack of such residue partic ularly eliminated the possible contribution of the first spacer in the inhibitor-enzyme interaction. In-deed, the new compound proved to be half less potent towards 4-NP glucuronidation and one third less potent towards PPh conversion (32% and 46% inhibition, respectively) than compound 1. These results confirm again the possible role of both spacers as well the stronger influence of the six-atom spacer on the U G T inhibition activity of the derivatives studied
In conclusion, 4-NP converting U G T isoforms respond more specifically to the inhibitors: a fiveatom first and a six-atom second spacers enhance binding to both, 4-NP and PPh conjugating isoen zymes, while a long second spacer contributes to inhibitor binding only to U G T isoforms convert ing PPh.
Thus, on the basis of the presented study, one can expect that new and potent U G T inhibitors could be designed not only by varying the acceptor substrate analogs but also allowing alternative spacers between the nucleoside and the aglycone moieties possibly to be involved in the enzymeinhibitor interaction.
